210 Users Online
Selective D2 antagonist market
Selective D2 antagonist is a class of dopamine antagonist drug type which blocks the dopamine receptor by a process called receptor antagonism. Most of the D2 antagonist are antipsychotics drugs which are helpful in treating mental disorders like schizophrenia, bipolar disorders, etc. These D2 receptors are found in several part of the body such as substantia nigra, hypothalamus, striatum, cortex, etc.
There is high demand of selective D2 antagonist drugs due to increasing cases of mental disorders and depression. Market players are trying to expand the therapeutic application of selective D2 antagonist drugs thus creating more opportunity and scope for the growth of the selective D2 antagonist market in the future.
Rising prevalence rate of mental disorders like schizophrenia and bipolar disorders are major factors driving growth of the selective D2 antagonist market. Expanding therapeutic use of these drugs by key market players are further expected to aid in the growth of the selective D2 antagonist market. The increasing awareness of people towards mental health is further anticipated to boost in growth of the selective D2 antagonist market.
High investment in research and development of these selective D2 antagonist drugs are further expected to fuel the growth of the selective D2 antagonist market. Increasing cases of depression and other mental illness may surge in the growth of the selective D2 antagonist market. However, there are several side effects associated with the use of selective D2 antagonist drugs which in turn hamper the growth of the selective D2 antagonist market.
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
| Drug Class |
|
| Application |
|
| route of administration |
|
| distribution channel |
|
| Region |
|
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Sales Team
Client Partner
